Share:
NeoImmuneTech receives FDA IND clearance for Phase 1 study of NT-I7 (efineptakin alfa) for the treatment of Kaposi Sarcoma in patients with or without HIV infection.
Read the full press release here.
Source : Business Wire
Related HIV and Co-Infections News
-
Barcelona Institute for Global Health: Expanded TB screening does not speed up treatment initiation or improve survival in hospitalised patients with HIV
-
CATIE: British Columbia study underscores the importance of the shingles vaccine for people with HIV
-
[CROI 2026] HIV i-Base: Nine comprehensive free reviews in Topics in Antiviral Medicine
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.